共 37 条
- [1] Conolly M.E., Kersting F., Dollery C.T., The clinical pharmacology of beta-adrenoceptor-blocking drugs, Prog Cardiovasc Dis, 19, pp. 203-234, (1976)
- [2] Man in't Veld A., Schalekamp M.A.D.H., Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: The key role of vascular resistance changes in relation to partial agonist activity, J Cardiovasc Pharmacol, 5, pp. S30-S45, (1983)
- [3] Lund-Johansen P., Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol, pindolol and bunitrolol, Eur Heart J, 4, pp. 1-12, (1983)
- [4] Atterhog J.H., Duner H., Pernow B., Experience with pindolol, a beta receptor blocker in the treatment of hypertension, Am J Med, 60, pp. 872-876, (1976)
- [5] Hansson L., Aberg H., Karlberg B.E., Westerlund A., Controlled study of atenolol in treatment of hypertension, Br Med J, 2, pp. 367-370, (1975)
- [6] Waal-Manning H.J., Hypertension: Which beta-blocker?, Drugs, 12, pp. 412-441, (1976)
- [7] Frishman W., Kostis J., Strom J., Et al., Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity, Am Heart J, 98, pp. 526-535, (1979)
- [8] Schiess W., Welzel D., Gugler R., Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension, Eur J Clin Pharmacol, 27, pp. 529-534, (1984)
- [9] Levy J.V., Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist, J Clin Pharmacol, 11, pp. 249-260, (1971)
- [10] Lubawski I., Wale J., Studies with LB 46, a new beta-receptor blocking drug, Eur J Pharmacol, 6, pp. 345-348, (1969)